CSIMarket
 


Steris Plc  (NYSE: STE)
Other Ticker:  
 

Steris Plc's Working Capital Ratio

STE's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth

 


In the wake of the increase in Current Liabilities in the fourth quarter 2025, Working Capital Ratio fell to 2.03 a new company low.

Within Medical Equipment & Supplies industry 102 other companies have achieved higher Working Capital Ratio than Steris Plc in fourth quarter 2025. While Working Capital Ratio total ranking has improved so far during the Q4 2025 to 1609, from total ranking in the third quarter 2024 at 1955.

Explain Working Capital Ratio
How much Current Assetss STE´s has?
What are STE´s Current Liabilities?


STE Working Capital Ratio (Mar 31 2025)
Q4
(Dec 31 2024)
Q3
(Sep 30 2024)
Q2
(Jun 30 2024)
Q1
(Mar 31 2024)
Q4
Y / Y Current Liabilities Change 9.79 % -2.09 % -7.63 % -5.61 % 8.83 %
Y / Y Current Assets Change -30.27 % -14.47 % -10.86 % -4.47 % 42.64 %
Working Capital Ratio MRQ 2.03 2.21 2.5 2.41 3.19
STE's Total Ranking # 1609 # 1955 # 1637 # 1730 # 0
Seq. Current Liabilities Change 15.06 % 10.8 % -3.69 % -10.58 % 2.61 %
Seq. Current Assets Change 5.42 % -2.06 % -0.14 % -32.37 % 29.3 %



Working Capital Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 103
Healthcare Sector # 541
Overall Market # 1609


Working Capital Ratio Statistics
High Average Low
3.19 2.62 2.03
(Sep 30 2013)   (Mar 31 2025)




Financial Statements
Steris Plc's Current Liabilities $ 988 Millions Visit STE's Balance sheet
Steris Plc's Current Assets $ 2,001 Millions Visit STE's Balance sheet
Source of STE's Sales Visit STE's Sales by Geography


Cumulative Steris Plc's Working Capital Ratio

STE's Working Capital Ratio for the trailling 12 Months

STE Working Capital Ratio

(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -1.21 % -1.68 % 2.34 % 4.29 % 5.1 %
Y / Y Current Assets TTM Growth -16.32 % 2.49 % 9.44 % 16.38 % 20.31 %
Working Capital Ratio TTM 2.27 2.59 2.67 2.69 2.68
Total Ranking TTM # 2705 # 2017 # 3524 # 1130 # 0
Seq. Current Liabilities TTM Growth 2.64 % -0.55 % -1.87 % -1.38 % 2.15 %
Seq. Current Assets TTM Growth -10.04 % -3.58 % -2.57 % -0.98 % 10.17 %


On the trailing twelve months basis Due to increase in Current Liabilities in the Q4 2025 to $987.97 millions, cumulative Working Capital Ratio decreased to 2.27 below the Steris Plc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 145 other companies have achieved higher Working Capital Ratio than Steris Plc. While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2024 from 2017 to 2705.

Explain Working Capital Ratio
How much Current Assetss STE´s has?
What are STE´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 146
Healthcare Sector # 727
Within the Market # 2705


trailing twelve months Working Capital Ratio Statistics
High Average Low
3.06 2.6 2.19
(Dec 31 2013)   (Mar 31 2025)




Companies with similar Working Capital Ratio in the quarter ending Mar 31 2025, within Medical Equipment & Supplies Industry Working Capital RatioMar 31 2025 MRQ Current AssetsMar 31 2025 MRQ Current Liabilities
Artivion Inc   5.53 $ 287.297  Millions$ 51.940  Millions
Tenon Medical Inc  5.46 $ 11.990  Millions$ 2.195  Millions
Heartbeam Inc   5.46 $ 8.608  Millions$ 1.578  Millions
Apyx Medical Corp  5.45 $ 51.851  Millions$ 9.510  Millions
Electromed Inc   5.19 $ 44.195  Millions$ 8.511  Millions
Surmodics Inc   5.14 $ 71.747  Millions$ 13.950  Millions
Merit Medical Systems Inc  5.12 $ 958.635  Millions$ 187.388  Millions
Intuitive Surgical Inc   4.98 $ 7,657.800  Millions$ 1,538.100  Millions
Pulmonx Corporation  4.97 $ 123.939  Millions$ 24.945  Millions
Endra Life Sciences Inc   4.96 $ 2.180  Millions$ 0.440  Millions
Tactile Systems Technology Inc   4.95 $ 160.122  Millions$ 32.365  Millions
Staar Surgical Co  4.78 $ 326.498  Millions$ 68.356  Millions
Axogen inc   4.73 $ 93.070  Millions$ 19.658  Millions
Biolife Solutions Inc   4.73 $ 131.129  Millions$ 27.723  Millions
Zynex inc   4.72 $ 56.414  Millions$ 11.945  Millions
Mimedx Group Inc   4.70 $ 200.112  Millions$ 42.619  Millions
Nexalin Technology Inc   4.56 $ 2.621  Millions$ 0.575  Millions
Treace Medical Concepts Inc   4.50 $ 149.437  Millions$ 33.180  Millions
Insulet Corporation  4.47 $ 2,328.400  Millions$ 520.400  Millions
Edwards Lifesciences Corporation  4.45 $ 6,212.700  Millions$ 1,394.800  Millions
Globus Medical Inc   4.45 $ 1,710.114  Millions$ 384.701  Millions
Medinotec Inc   4.35 $ 6.423  Millions$ 1.477  Millions
Tela Bio Inc   4.22 $ 69.745  Millions$ 16.536  Millions
Atricure Inc   4.11 $ 251.484  Millions$ 61.221  Millions
Lakeland Industries Inc   3.88 $ 140.706  Millions$ 36.267  Millions
Icad Inc  3.77 $ 28.122  Millions$ 7.458  Millions
Nutriband Inc   3.71 $ 3.430  Millions$ 0.925  Millions
Inogen Inc   3.58 $ 200.708  Millions$ 56.096  Millions
Integer Holdings Corporation  3.55 $ 702.203  Millions$ 197.695  Millions
Cadre Holdings inc   3.55 $ 332.515  Millions$ 93.666  Millions

Date modified: 2025-06-01T10:44:19+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com